Evaluation reveals associations between total antibodies and long covid symptoms, suggesting immune differences in vaccinated and unvaccinated individuals.
Introduction: Long COVID is an infection-associated chronic condition that occurs after SARS-CoV-2 infection and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state. While COVID-19 vaccines have been credited with prevention of COVID associated morbidity and mortality, a portion of the population reports post-vaccination syndrome often concerning for Long COVID. Methods: To investigate the association between post-vaccination syndrome and Long COVID, we evaluated SARS-CoV-2 Semi-Quant Spike Ab in 100 consecutive patients with symptoms of Long COVID. Results: A total of 81 participants with post-vaccination syndrome and 19 unvaccinated participants with symptoms of Long COVID were evaluated. SARS-CoV-2 Semi-Quant Spike Ab in the vaccinated cohort showed an average result of 11356.86, while SARS-CoV-2 Semi-Quant Spike Ab in the unvaccinated cohort showed an average result of 1631.94. Conclusions: The findings reveal potential immune differences in both individuals with Long Covid and those with post-vaccination syndrome that merit further investigation to better understand these conditions and inform future research into diagnostic and therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
White et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: